aminoglutethimide has been researched along with Ache in 5 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Excerpt | Relevance | Reference |
---|---|---|
"One hundred twenty-eight women with advanced metastatic breast cancer were treated with a combination of aminoglutethimide (AG) (1000 mg orally, daily) and medroxyprogesterone acetate (MPA) (1500 mg orally, daily for six weeks and thereafter 500 mg orally, daily; omitting cortisone substitution)." | 7.67 | Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO). ( Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE, 1986) |
"Seventy-three women with metastatic breast cancer were treated with aminoglutethimide and dexamethasone." | 7.66 | Treatment of metastatic breast cancer with aminoglutethimide. ( Asbury, RF; Bakemeier, RF; Bennett, JM; Fölsch, E; McCune, CS; Savlov, E, 1981) |
"One hundred twenty-eight women with advanced metastatic breast cancer were treated with a combination of aminoglutethimide (AG) (1000 mg orally, daily) and medroxyprogesterone acetate (MPA) (1500 mg orally, daily for six weeks and thereafter 500 mg orally, daily; omitting cortisone substitution)." | 3.67 | Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO). ( Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE, 1986) |
"Seventy-three women with metastatic breast cancer were treated with aminoglutethimide and dexamethasone." | 3.66 | Treatment of metastatic breast cancer with aminoglutethimide. ( Asbury, RF; Bakemeier, RF; Bennett, JM; Fölsch, E; McCune, CS; Savlov, E, 1981) |
" Drug intervention should be on a regular schedule--avoid prn dosage of pain medications." | 1.27 | Dilemmas in managing prostate carcinoma (Part II): Metastatic disease. ( Ahmann, FR, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asbury, RF | 1 |
Bakemeier, RF | 1 |
Fölsch, E | 1 |
McCune, CS | 1 |
Savlov, E | 1 |
Bennett, JM | 1 |
Bonneterre, J | 1 |
Adenis, A | 1 |
Pion, JM | 1 |
Cambier, L | 1 |
Kamus, E | 1 |
Hecquet, B | 1 |
Wander, HE | 1 |
Nagel, GA | 1 |
Blossey, HC | 1 |
Kleeberg, U | 1 |
Elomaa, I | 1 |
Taube, T | 1 |
Blomqvist, C | 1 |
Rissanen, P | 1 |
Rannikko, S | 1 |
Alfthan, O | 1 |
Ahmann, FR | 1 |
5 other studies available for aminoglutethimide and Ache
Article | Year |
---|---|
Treatment of metastatic breast cancer with aminoglutethimide.
Topics: Aminoglutethimide; Breast Neoplasms; Dexamethasone; Female; Hormones; Humans; Middle Aged; Nausea; N | 1981 |
Aminoglutethimide (AG) and hydrocortisone (HC) in bone metastases: a retrospective study.
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; | 1993 |
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO).
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brea | 1986 |
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Bone Neoplasms; Drug Therapy, Combination; Humans; Hydro | 1988 |
Dilemmas in managing prostate carcinoma (Part II): Metastatic disease.
Topics: Aged; Aminoglutethimide; Aspirin; Bone Neoplasms; Castration; Diethylstilbestrol; Disseminated Intra | 1985 |